Gary Burke, DO - Medicare Cardiovascular Disease (cardiology) in Cherry Hill, NJ

Gary Burke, DO is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Cherry Hill, New Jersey. He went to Philadelphia College Of Osteopathic Medicine and graduated in 1985 and has 39 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Virtua Medical Group, Pa and his current practice location is 1 Brace Rd Ste C1, Cherry Hill, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 428-4100.

Gary Burke is licensed to practice in New Jersey (license number 25MB05163700) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1598744898.

Contact Information

Gary Burke, DO
1 Brace Rd Ste C1,
Cherry Hill, NJ 08034-2600
(856) 428-4100
(856) 428-5748



Physician's Profile

Full NameGary Burke
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience39 Years
Location1 Brace Rd Ste C1, Cherry Hill, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Gary Burke attended and graduated from Philadelphia College Of Osteopathic Medicine in 1985
  NPI Data:
  • NPI Number: 1598744898
  • Provider Enumeration Date: 01/13/2006
  • Last Update Date: 04/14/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 6800850272
  • Enrollment ID: I20041116000165

Medical Identifiers

Medical identifiers for Gary Burke such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598744898NPI-NPPES
7365608MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 25MB05163700 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Virtua Our Lady Of Lourdes HospitalCamden, NJHospital
Virtua West Jersey HospitalsVoorhees, NJHospital
Virtua Memorial Hospital Of Burlington CountyMount holly, NJHospital
Cooper University HospitalCamden, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Virtua Medical Group, Pa98302223971226

News Archive

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

Johns Hopkins joins with imec to advance silicon applications in health care

Researchers and physicians at The Johns Hopkins University will collaborate with Belgian nanoelectronics research center imec to advance silicon applications in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory.

Marker for new blood vessel formation in tumors

In a paper in this month's freely-available online global health journal PLoS Medicine, Roland Haubner and colleagues describe how a compound they have developed can be used together with highly sensitive positron emission tomography (PET) scanning to measure the amount of new blood vessel growth in some tumors.

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gary Burke allows following entities to bill medicare on his behalf.
Entity NameVirtua Medical Group, Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649226515
PECOS PAC ID: 9830222397
Enrollment ID: O20100804000338

News Archive

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

Johns Hopkins joins with imec to advance silicon applications in health care

Researchers and physicians at The Johns Hopkins University will collaborate with Belgian nanoelectronics research center imec to advance silicon applications in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory.

Marker for new blood vessel formation in tumors

In a paper in this month's freely-available online global health journal PLoS Medicine, Roland Haubner and colleagues describe how a compound they have developed can be used together with highly sensitive positron emission tomography (PET) scanning to measure the amount of new blood vessel growth in some tumors.

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

Read more Medical News

› Verified 6 days ago

Entity NameLourdes Cardiology Services, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912202557
PECOS PAC ID: 5799961751
Enrollment ID: O20110510000163

News Archive

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

Johns Hopkins joins with imec to advance silicon applications in health care

Researchers and physicians at The Johns Hopkins University will collaborate with Belgian nanoelectronics research center imec to advance silicon applications in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory.

Marker for new blood vessel formation in tumors

In a paper in this month's freely-available online global health journal PLoS Medicine, Roland Haubner and colleagues describe how a compound they have developed can be used together with highly sensitive positron emission tomography (PET) scanning to measure the amount of new blood vessel growth in some tumors.

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gary Burke is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gary Burke, DO
301 Lippincott Dr Ste 410,
Marlton, NJ 08053-4197

Ph: (856) 355-0340
Gary Burke, DO
1 Brace Rd Ste C1,
Cherry Hill, NJ 08034-2600

Ph: (856) 428-4100

News Archive

CyberKnife radiosurgery studies for breast cancer treatment to be presented at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4.

Johns Hopkins joins with imec to advance silicon applications in health care

Researchers and physicians at The Johns Hopkins University will collaborate with Belgian nanoelectronics research center imec to advance silicon applications in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory.

Marker for new blood vessel formation in tumors

In a paper in this month's freely-available online global health journal PLoS Medicine, Roland Haubner and colleagues describe how a compound they have developed can be used together with highly sensitive positron emission tomography (PET) scanning to measure the amount of new blood vessel growth in some tumors.

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Cherry Hill, NJ

Shagufta Ahsan, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003
Phone: 917-808-5942    
Dr. Alexandr Zaslavsky, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002
Phone: 856-406-0023    
Dr. Tolulope Adesiyun Agunbiade, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034
Phone: 856-482-8900    
Garo Charles Avetian, D.O.
Cardiovascular Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003
Phone: 856-761-8100    Fax: 856-761-8107
Matthew Everwine, DO
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002
Phone: 856-513-4124    
Dr. Behjath Jafry, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034
Phone: 856-428-6616    Fax: 856-428-4823
William C Groh, MD
Cardiovascular Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034
Phone: 856-216-0300    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.